Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
British Journal of Clinical Pharmacology|May 12, 2019
The rationale of dose-response curves in selecting cancer drug dosingJennifer H Martin, Simon DimmittAustralasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|March 22, 2005
Severe tachycardia following low-dose clozapine treatmentHans Stampfer, Peter SwanepoelInternal Medicine Journal|December 5, 2023
The valley of death: why Australia failed to develop clinically effective drugs in COVID-19Jennifer H MartinBritish Journal of Clinical Pharmacology|May 17, 2018
Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modellingZheng Liu, Jennifer H MartinBritish Journal of Clinical Pharmacology|September 22, 2020
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19Jennifer H Martin, Richard HeadInternal Medicine Journal|October 20, 2022
Complementary and alternative therapies in the palliative settingJennifer H Martin, Joanne PatelClinical Science (London, England : 1979)|June 30, 2007
Statins and clinical outcomes in heart failureJennifer H Martin, Henry KrumJournal of Clinical Pharmacology|September 19, 2017
Pharmacokinetic-Guided Dosing of New Oral Cancer AgentsCatherine J Lucas, Jennifer H MartinClinical Pharmacokinetics|February 18, 2016
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia SyndromeStephanie E Reuter, Jennifer H MartinExpert Opinion on Pharmacotherapy|January 24, 2017
Lipid and other management to improve arterial disease and survival in end stage renal diseaseSimon B Dimmitt, Jennifer H MartinPageof 15